Bosh sahifaABUS • NASDAQ
add
Arbutus Biopharma Corp
4,52 $
Dastlabki sotuv:(0,93%)-0,042
4,48 $
Yopilgan:2-apr, 4:00:00 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
4,50 $
Kunlik diapazon
4,47 $ - 4,62 $
Yillik diapazon
2,71 $ - 5,10 $
Bozor kapitalizatsiyasi
883,56 mln USD
Oʻrtacha hajm
2,67 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,05 mln | -33,23% |
Joriy xarajat | 3,69 mln | -21,71% |
Sof foyda | -3,76 mln | 70,03% |
Sof foyda marjasi | -357,37 | 55,11% |
Har bir ulushga tushum | — | — |
EBITDA | -7,63 mln | 34,28% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 91,47 mln | -25,40% |
Jami aktivlari | 94,62 mln | -28,16% |
Jami passivlari | 18,04 mln | -47,46% |
Umumiy kapital | 76,58 mln | — |
Tarqatilgan aksiyalar | 195,48 mln | — |
Narxi/balansdagi bahosi | 11,25 | — |
Aktivlardan daromad | -19,87% | — |
Kapitaldan daromad | -23,48% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -3,76 mln | 70,03% |
Operatsiyalardan naqd pul | -4,68 mln | 54,63% |
Sarmoyadan naqd pul | -1,36 mln | -110,15% |
Moliyadan naqd pul | 1,64 mln | 15,41% |
Naqd pulning sof oʻzgarishi | -4,40 mln | -198,13% |
Boʻsh pul | -1,95 mln | 77,37% |
Haqida
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Tashkil etilgan
2007
Sayt
Xodimlar soni
19
